Missouri marijuana processor Delta Extraction has lost its final appeal, resulting in the termination of its business license after its role in a massive 2023 product recall.

According to the Missouri Independent, the state’s Administrative Hearing Commission this week upheld an earlier decision by state regulators who suspended Delta Extraction’s marijuana business license in August 2023, accusing the company of sourcing materials from an unlicensed facility.

ADVERTISEMENT

The commission essentially agreed with the Division of Cannabis Regulation (DCR) that Delta Extraction violated Missouri law by infusing products with THCA sourced from outside the state.

In a 137-page ruling issued Tuesday, the Administrative Hearing Commission said the company had a “corporate culture of lax compliance with regulatory requirements,” the Independent reported.

An attorney representing

Read full article on Marijuana Business Daily

(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.)

Pam Chmiel (Courtesy photo)

2025 is poised to be a pivotal year for partnerships between the cannabis industry and universities, both in the United States and globally.

While academic collaborations are not a new concept, the cannabis industry has been slow to embrace them – mainly because marijuana is illegal on the federal level in the United States.

ADVERTISEMENT

However, as the industry matures, these partnerships represent the next logical step for companies with the vision and resources to drive innovation, influence policy and shape the future of cannabis.

The potential for collaboration spans research partnerships, sponsored research agreements, joint ventures and licensing arrangements through technology transfer agreements.

Read full article on Marijuana Business Daily

The latest foray into the legal marijuana industry by MedMen Enterprises co-founders Adam Bierman and Andrew Modlin rapidly collapsed amid lawsuits alleging unpaid bills and a dispute with a business partner, court records and public licensing information show.

Megabud – described as a “chain of cannabis convenience stores” – launched in December 2022 with three locations in the San Francisco Bay Area.

ADVERTISEMENT

The chain, which had ambitious expansion plans, represented at least the third legal cannabis venture for Bierman and Modlin, whose infamous tenure as MedMen executives saw the marijuana multistate operator go public on the Canadian Securities Exchange with an implied valuation of $2 billion before an equally spectacular implosion.

A second cannabis retail chain in which Bierman and Modlin owned a

Read full article on Marijuana Business Daily